Bonraybio Revenue

In the year 2025, Bonraybio had annual revenue of 306.31M TWD with 37.43% growth. Bonraybio had revenue of 82.23M in the quarter ending December 31, 2025, with 30.48% growth.

Revenue

306.31M

Revenue Growth

+37.43%

P/S Ratio

13.52

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.14B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	306.31M	83.43M	37.43%
Dec 31, 2024	222.88M	63.24M	39.61%
Dec 31, 2023	159.64M	53.37M	50.22%
Dec 31, 2022	106.27M	49.98M	88.78%
Dec 31, 2021	56.30M	29.71M	111.71%
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
WeLeader Biomedical	1.11B
Delta Asia International	694.15M
Hi-Clearance	4.28B
Medimaging Integrated Solution	661.39M
A Plus Biotechnology	835.89M
Dynamic Medical Technologies	1.39B
Applied BioCode	475.20M
Wellell	2.40B

Revenue Rankings